ChondroFiller for focal knee defects versus early osteoarthritisFocal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
Who qualifies for ChondroFiller injectionChondroFiller targets Grade III and IV cartilage damage—focal defects or distributed osteoarthritis—using a collagen scaffold to support biological repair across both presentations, provided joint mechanical stability remains intact.ChondroFiller targets Grade III and IV cartilage damage—focal defects or distributed osteoarthritis—using a collagen scaffold to support biological repair across both presentations, provided joint mechanical stability remains intact.
Who qualifies for ChondroFiller injectionChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.ChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.